Pharsight

Drugs that contain Plerixafor

1. Mozobil patents expiration

MOZOBIL's oppositions filed in EPO
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
USRE42152 GENZYME Aromatic-linked polyamine macrocyclic compounds with anti-HIV activity
Dec, 2018

(5 years ago)

US6987102 GENZYME Methods to mobilize progenitor/stem cells
Jul, 2023

(10 months ago)

US7897590 GENZYME Methods to mobilize progenitor/stem cells
Jul, 2023

(10 months ago)

Drug Exclusivity Drug Exclusivity Expiration
Orphan Drug Exclusivity(ODE) Dec 15, 2015
New Chemical Entity Exclusivity(NCE) Dec 15, 2013

NCE-1 date: 15 December, 2012

Market Authorisation Date: 15 December, 2008

Treatment: Use in combination with granulocyte-colony stimulating factor (g-csf) to mobilize hematopoietic stem cells to peripheral blood for collection & subsequent autologous transplantation in patients with n...

Dosage: SOLUTION;SUBCUTANEOUS

How can I launch a generic of MOZOBIL before it's drug patent expiration?
More Information on Dosage

MOZOBIL family patents

Family Patents